|
|
|
Researchers at The Ottawa Hospital awarded 10 CIHR grants worth more than $7 million
July 21,
2025
-
Researchers at The Ottawa Hospital have been awarded more than $7 million from the Canadian Institutes of Health Research (CIHR) to lead 10 cutting-edge research projects.
|
|
|
|
|
|
The Ottawa Hospital joins landmark bipolar disorder research network BD2
July 8,
2025
-
The Ottawa Hospital’s Research Institute has been awarded US$ 2.3 million to join Breakthrough Discoveries for thriving with Bipolar Disorder (BD²).
|
|
|
|
|
|
OHRI partners with clinical departments, uOttawa and Faculty of Medicine to support 40 Clinical Research Chairs
June 27,
2025
-
The Ottawa Hospital Research Institute (OHRI) is supporting 40 Clinical Research Chairs as part of a new partnership with clinical departments, uOttawa’s Faculty of Medicine and uOttawa’s Office of the Vice-President, Research and Innovation.
|
|
|
|
|
|
MicroRNA for MS: Mouse study sparks potential new treatment approach
June 26,
2025
-
It’s easy to forget the delicate balance inside the human body until something goes wrong. For people with multiple sclerosis (MS), that moment comes when the immune system mistakenly attacks myelin—the fatty insulating layer that protects nerve ...
|
|
|
|
|
|
Pioneering biotherapeutics trial paves the way for innovative approaches to treat pulmonary arterial hypertension
June 20,
2025
-
Pulmonary arterial hypertension (PAH) is a rare and deadly disease that involves progressive damage to the tiny blood vessels that feed the lungs. In most cases, the cause is unknown and treatments are limited.
|
|
|
|
See all news items | See only press releases | Search for news and experts by disease / specialty
|
|
|
Media contacts
Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca
|
